SLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemia.

SLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemia.

OBJECTIVE: This study aimed to explore the influence of SLC22A1, PXR, ABCG2, ABCB1 and CYP3A5 3 genetic polymorphisms on imatinib mesylate (IM) pharmacokinetics in Asian patients with chronic myeloid leukemia (CML). PATIENTS AND METHODS: Healthy subjects belonging to three Asian populations (Chinese...

Full description

Bibliographic Details
Main Authors:	Onkar Singh, Jason Yongsheng Chan, Keegan Lin, Charles Chuah Thuan Heng, Balram Chowbay
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3525665?pdf=render

Similar Items

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment
by: Monika Jaruskova, et al.
Published: (2017-04-01)

Association of ABCB1 and FLT3 Polymorphisms with Toxicities and Survival in Asian Patients Receiving Sunitinib for Renal Cell Carcinoma.
by: Ying-Hsia Chu, et al.
Published: (2015-01-01)

Lack of association of ABCB1 haplotypes on five loci with response to treatment in epilepsy
by: Haerian, B.S., et al.
Published: (2011)

The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response
by: Ningrum, Vitarani Dwi Ananda, et al.
Published: (2022)

The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response.
by: Vitarani Dwi Ananda Ningrum, et al.
Published: (2022-01-01)

Genetic polymorphisms and haplotypes of the organic cation transporter 1 gene (SLC22A1) in the Xhosa population of South Africa
by: Clifford Jacobs, et al.
Published: (2014-04-01)

Genetic polymorphisms and haplotypes of the organic cation transporter 1 gene (SLC22A1) in the Xhosa population of South Africa
by: Clifford Jacobs, et al.
Published: (2014-06-01)

ABCB1 haplotypes do not influence transport or efficacy of tyrosine kinase inhibitors in vitro
by: Skoglund K, et al.
Published: (2013-08-01)

Genotype and haplotype analysis of ABCB1 at 1236, 2677 and 3435 among systemic sclerosis patients
by: Małgorzata Barańska, et al.
Published: (2017-07-01)

<it>ABCB1 </it>genotypes and haplotypes in patients with dementia and age-matched non-demented control patients
by: Frankfort Suzanne V, et al.
Published: (2006-09-01)

Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
by: Karin Brecht, et al.
Published: (2020-08-01)

Population pharmacokinetics of lenalidomide in Chinese patients with influence of genetic polymorphisms of ABCB1
by: Xiaoxiao Liang, et al.
Published: (2024-01-01)

Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1
by: Alexandra L. Degraeve, et al.
Published: (2023-07-01)

Association of ABCB1 and SLC22A16 Gene Polymorphisms with Incidence of Doxorubicin-Induced Febrile Neutropenia: A Survey of Iranian Breast Cancer Patients.
by: Abolfazl Faraji, et al.
Published: (2016-01-01)

Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels
by: Laith N. AL-Eitan, et al.
Published: (2019-03-01)

Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study
by: Thomas Boyer, et al.
Published: (2019-09-01)

Towards Comprehension of the ABCB1/P-Glycoprotein Role in Chronic Myeloid Leukemia
by: Raquel C. Maia, et al.
Published: (2018-01-01)

SLC22A1, SLC22A2, SLC22A3 and 11ßHSD1 gene polymorphisms among Malaysian Indians with type 2 diabetes mellitus
by: Abood, Al Ashoor Sabah Ghasan
Published: (2019)

Imatinib en leucemia mieloide crónica Imatinib in chronic myeloid leukemia
by: Valia Pavón Morán, et al.
Published: (2005-12-01)

Association of ABCB1 gene polymorphisms and their haplotypes with response to antiepileptic drugs: a systematic review and meta-analysis
by: Haerian, B.S., et al.
Published: (2011)

Wnt/β-catenin pathway regulates <it>ABCB1</it> transcription in chronic myeloid leukemia
by: Corrêa Stephany, et al.
Published: (2012-07-01)

Beyond Single Nucleotide Polymorphisms: CYP3A5∗3∗6∗7 Composite and ABCB1 Haplotype Associations to Tacrolimus Pharmacokinetics in Black and White Renal Transplant Recipients
by: Daniel A. Brazeau, et al.
Published: (2020-08-01)

IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
by: Tomasz Sacha
Published: (2013-12-01)

Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer
by: Ruben A. G. van Eerden, et al.
Published: (2021-11-01)

Impact of <i>ABCG2</i> and <i>ABCB1</i> Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis
by: Chiara Dalle Fratte, et al.
Published: (2023-02-01)

PB1790: ABCB1 AS A POTENTIAL BENEFICIAL TARGET OF MIDOSTAURIN IN ACUTE MYELOID LEUKEMIA
by: S. Sucha, et al.
Published: (2022-06-01)

Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response.
by: Francina Fonseca, et al.
Published: (2011-05-01)

Imatinib Mesylate Treatment in Chronic Myeloid Leukemia
by: Demet Çekdemir, et al.
Published: (2020-03-01)

Application of physiologically based pharmacokinetic modeling to understand real‐world outcomes in patients receiving imatinib for chronic myeloid leukemia
by: Josephine A. Adattini, et al.
Published: (2023-08-01)

DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA
by: Buket Altinok Gunes, et al.
Published: (2023-01-01)

Genetic Variation in <i>CYP2D6</i> and <i>SLC22A1</i> Affects Amlodipine Pharmacokinetics and Safety
by: Paula Soria-Chacartegui, et al.
Published: (2023-01-01)

Association of <i>SLC22A1</i>, <i>SLC22A2</i>, <i>SLC47A1</i>, and <i>SLC47A2</i> Polymorphisms with Metformin Efficacy in Type 2 Diabetic Patients
by: Peixian Chen, et al.
Published: (2022-10-01)

Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter
by: Darren eMoss, et al.
Published: (2015-04-01)

Role of ABCB1 and ABCB4 in renal and biliary excretion of perfluorooctanoic acid in mice
by: Kazuyoshi Furukawa, et al.
Published: (2024-03-01)

P1537: HEREDITARY ANEMIA CAUSED BY MULTILOCUS INHERITANCE OF PIEZO1, SLC4A1 AND ABCB6 MUTATIONS: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE.
by: B. E. Rosato, et al.
Published: (2022-06-01)

Optimal response to imatinib therapy in a case of chronic myeloid leukemia with a concurrent loss of distal 22q
by: Bayan Alqahtany, et al.
Published: (2017-01-01)

Adverse effects of Imatinib in patients with chronic myeloid leukemia
by: Hajar Masrour, et al.
Published: (2023-01-01)

Stem Cell Responsiveness to Imatinib in Chronic Myeloid Leukemia
by: Rachid Lahlil, et al.
Published: (2023-11-01)

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
by: Radhakrishnan Ramchandren, et al.
Published: (2009-05-01)

Renal tuberculosis in an imatinib-treated chronic myeloid leukemia
by: Abhilash Chandra, et al.
Published: (2020-04-01)